I. Babina

发表

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

Sue Chua, Alex Pearson, James Campbell, 2016, Cancer discovery.

Gatekeeper Mutations and Intratumoral Heterogeneity in FGFR2-Translocated Cholangiocarcinoma.

N. Turner, E. Smyth, I. Babina, 2017, Cancer discovery.

Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration.

I. Nabi, A. Hopkins, I. Babina, 2012, The American journal of pathology.

Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier.

L. Hudson, A. Hopkins, S. Walsh, 2012, American journal of physiology. Gastrointestinal and liver physiology.

The Controlling Cancer Summit, 17-19 May 2016, London, UK.

I. Babina, 2016, Future oncology.

Advances and challenges in targeting FGFR signalling in cancer

N. Turner, I. Babina, Nicholas C. Turner, 2017, Nature Reviews Cancer.

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer

C. Bakal, J. Giltnane, A. Barr, 2017, Clinical Cancer Research.

Lipid Rafts as Master Regulators of Breast Cancer Cell Function

I. Nabi, A. Hopkins, I. Babina, 2011 .

A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44

A. Hill, E. McSherry, A. Hopkins, 2014, Breast Cancer Research.

Identification of subtypes of triple negative breast cancer (TNBC) that are sensitive to CDK4/6 inhibition.

U. Asghar, N. Turner, M. T. Herrera-Abreu, 2015 .

Molecular determinants of sensitivity and resistance to FGFR inhibition in FGFR2-amplified gastric cancer

Jian Ning, A. Swain, N. Turner, 2016 .

Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier.

L. Hudson, A. Hopkins, S. Walsh, 2012, American journal of physiology. Gastrointestinal and liver physiology.

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

D. Cunningham, K. Fenwick, Jian Ning, 2016, Cancer discovery.

Tumorigenesis and Neoplastic Progression Lipid Raft Association Restricts CD 44-Ezrin Interaction and Promotion of Breast Cancer Cell Migration

I. Nabi, A. Hopkins, I. Babina, 2012 .

Gatekeeper Mutations and Intratumoral Heterogeneity in FGFR2-Translocated Cholangiocarcinoma.

N. Turner, E. Smyth, I. Babina, 2017, Cancer discovery.